Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Cisplatin: carboplatin"'
Autor:
Mahfujul Ahmed Riad
Publikováno v:
Asian Pacific Journal of Cancer Biology, Vol 7, Iss 2, Pp 151-155 (2022)
Introduction: Head and neck cancers are the common cancers in developing countries, especially in Southeast Asia. Concurrent chemoradiation is the treatment of choice for locally advanced stage III to IVB squamous cell carcinoma of head and neck. Car
Externí odkaz:
https://doaj.org/article/95c55042bfc44ac7a91ffcbe3f8a3a5e
Autor:
Thorsten Langer, Eva Clemens, Linda Broer, Lara Maier, André G. Uitterlinden, Andrica C.H. de Vries, Martine van Grotel, Saskia F.M. Pluijm, Harald Binder, Benjamin Mayer, Annika von dem Knesebeck, Julianne Byrne, Eline van Dulmen-den Broeder, Marco Crocco, Desiree Grabow, Peter Kaatsch, Melanie Kaiser, Claudia Spix, Line Kenborg, Jeanette F. Winther, Catherine Rechnitzer, Henrik Hasle, Tomas Kepak, Anne-Lotte F. van der Kooi, Leontien C. Kremer, Jarmila Kruseova, Stefan Bielack, Benjamin Sorg, Stefanie Hecker-Nolting, Claudia E. Kuehni, Marc Ansari, Martin Kompis, Heleen J. van der Pal, Ross Parfitt, Dirk Deuster, Peter Matulat, Amelie Tillmanns, Wim J.E. Tissing, Jörn D. Beck, Susanne Elsner, Antoinette am Zehnhoff-Dinnesen, Marry M. van den Heuvel-Eibrink, Oliver Zolk
Publikováno v:
Data in Brief, Vol 32, Iss , Pp 106227- (2020)
Genetic association studies suggest a genetic predisposition for cisplatin-induced ototoxicity. Among other candidate genes, thiopurine methyltransferase (TPMT) is considered a critical gene for susceptibility to cisplatin-induced hearing loss in a p
Externí odkaz:
https://doaj.org/article/35d55296833a41b88236d9c151db2d3e
Autor:
Kishore Kumar, Rafeeq Ahmed, Chime Chukwunonso, Hassan Tariq, Masooma Niazi, Jasbir Makker, Ariyo Ihimoyan
Publikováno v:
Case Reports in Oncology, Vol 11, Iss 3, Pp 676-681 (2018)
Neuroendocrine cells are widespread throughout the body and can give rise of neuroendocrine tumors due to abnormal growth of the chromaffin cells. Neuroendocrine tumors divide into many subtypes based on tumor grade (Ki-67 index and mitotic count) an
Externí odkaz:
https://doaj.org/article/6b166d5e7264413f8c6520c5c2d5cbca
Autor:
Marcello Tiseo, Andrea Ardizzoni
Publikováno v:
Oncology Reviews, Vol 1, Iss 3, Pp 162-169 (2011)
Cisplatin has a pivotal role in the treatment of non-small cell lung cancer (NSCLC). However, it is associated with a number of serious and unpleasant side effects (nausea-vomiting, myelo-suppression, neuro-toxicity and renal function impairment). To
Externí odkaz:
https://doaj.org/article/9314fb845ba04af7bd3954c9fc4621c5
Publikováno v:
Chinese Journal of Lung Cancer, Vol 14, Iss 1, Pp 54-57 (2011)
Background and objective Since the poor outcome for advanced lung cancer with first-line chemotherapy, more efforts should be paid for treatment of advanced recurrent or metastasis non-small cell lung cancer (NSCLC) patients. Pemetrexed, as a multi-t
Externí odkaz:
https://doaj.org/article/78e487aa0e0a48d38049767bf462b6c8
Publikováno v:
Chinese Journal of Lung Cancer, Vol 12, Iss 1, Pp 38-43 (2009)
Background and objective Platinum plus the third-generation agent doublet chemotherapy is the standard regimens and first line chemotherapy for advanced non-small cell lung cancer (NSCLC). The aim of this study is to determine the benefits and harms
Externí odkaz:
https://doaj.org/article/8e15c19c934344edbc95cd734e9abd4b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Cureus
Tubulocystic carcinoma of the kidney is a rare neoplasm with
Autor:
Thorsten Langer, Eva Clemens, Linda Broer, Lara Maier, Andre G. Uitterlinden, Andrica C. H. de Vries, Martine van Grotel, Saskia F.M. Pluijm, Harald Binder, Benjamin Mayer, Annika von dem Knesebeck, Julianne Byrne, Eline van Dulmen-den Broeder, Marco Crocco, Desiree Grabow, Peter Kaatsch, Melanie Kaiser, Claudia Spix, Line Kenborg, Jeanette Falck Winther, Catherine Rechnitzer, Henrik Hasle, Tomas Kepak, Anne-Lotte F. van der Kooi, Leontien C. Kremer, Jarmila Kruseova, Stefan Bielack, Benjamin Sorg, Stefanie Hecker-Nolting, Claudia E. Kuehni, Marc Ansari, Martin Kompis, Heleen van der Pal, Ross Parfitt, Dirk Deuster, Peter Matulat, Amelie Tillmanns, Wim J. E. Tissing, Jörn D. Beck, Susanne Elsner, Antoinette am Zehnhoff-Dinnesen, Marry M. van den Heuvel-Eibrink, Oliver Zolk, PanCareLIFE Consortium Group
Publikováno v:
European Journal of Cancer, 138, 212-224. ELSEVIER SCI LTD
Langer, T, Clemens, E, Broer, L, Maier, L, Uitterlinden, A G, de Vries, A C H, van Grotel, M, Pluijm, S F M, Binder, H, Mayer, B, von dem Knesebeck, A, Byrne, J, van Dulmen-den Broeder, E, Crocco, M, Grabow, D, Kaatsch, P, Kaiser, M, Spix, C, Kenborg, L, Winther, J F, Rechnitzer, C, Hasle, H, Kepak, T, van der Kooi, A L F, Kremer, L C, Kruseova, J, Bielack, S, Sorg, B, Hecker-Nolting, S, Kuehni, C E, Ansari, M, Kompis, M, van der Pal, H, Parfitt, R, Deuster, D, Matulat, P, Tillmanns, A, Tissing, W J E, Beck, J D, Elsner, S, am Zehnhoff-Dinnesen, A, van den Heuvel-Eibrink, M M, Zolk, O & PanCareLIFE Consortium 2020, ' Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity : Results of the European PanCareLIFE cohort study ', European Journal of Cancer, vol. 138, pp. 212-224 . https://doi.org/10.1016/j.ejca.2020.07.019
European Journal of Cancer, 138, 212-224. Elsevier Limited
European Journal of Cancer, 138, 212-224. Elsevier Ltd.
European Journal of Cancer, 138, 212-224. Pergamon
European journal of cancer, Vol. 138 (2020) pp. 212-224
PanCareLIFE Consortium 2020, ' Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study ', European Journal of Cancer, vol. 138, pp. 212-224 . https://doi.org/10.1016/j.ejca.2020.07.019
Langer, T, Clemens, E, Broer, L, Maier, L, Uitterlinden, A G, de Vries, A C H, van Grotel, M, Pluijm, S F M, Binder, H, Mayer, B, von dem Knesebeck, A, Byrne, J, van Dulmen-den Broeder, E, Crocco, M, Grabow, D, Kaatsch, P, Kaiser, M, Spix, C, Kenborg, L, Winther, J F, Rechnitzer, C, Hasle, H, Kepak, T, van der Kooi, A L F, Kremer, L C, Kruseova, J, Bielack, S, Sorg, B, Hecker-Nolting, S, Kuehni, C E, Ansari, M, Kompis, M, van der Pal, H, Parfitt, R, Deuster, D, Matulat, P, Tillmanns, A, Tissing, W J E, Beck, J D, Elsner, S, am Zehnhoff-Dinnesen, A, van den Heuvel-Eibrink, M M, Zolk, O & PanCareLIFE Consortium 2020, ' Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity : Results of the European PanCareLIFE cohort study ', European Journal of Cancer, vol. 138, pp. 212-224 . https://doi.org/10.1016/j.ejca.2020.07.019
European Journal of Cancer, 138, 212-224. Elsevier Limited
European Journal of Cancer, 138, 212-224. Elsevier Ltd.
European Journal of Cancer, 138, 212-224. Pergamon
European journal of cancer, Vol. 138 (2020) pp. 212-224
PanCareLIFE Consortium 2020, ' Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study ', European Journal of Cancer, vol. 138, pp. 212-224 . https://doi.org/10.1016/j.ejca.2020.07.019
Background Irreversible sensorineural hearing loss is a common side effect of platinum treatment with the potential to significantly impair the neurocognitive, social and educational development of childhood cancer survivors. Genetic association stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74d8f2db88f78dbcfc6e239adea5886a
https://research.rug.nl/en/publications/3dda98e0-06d0-4a16-ad8d-a2a180e05ef0
https://research.rug.nl/en/publications/3dda98e0-06d0-4a16-ad8d-a2a180e05ef0